Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Nutex Health (NUTX) EBITDA: 2009-2024

Historic EBITDA for Nutex Health (NUTX) over the last 16 years, with FY2024 value amounting to $130.7 million.

  • Nutex Health's EBITDA rose 124913.59% to $130.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $358.9 million, marking a year-over-year increase of 378766.26%. This contributed to the annual value of $130.7 million for FY2024, which is 51133.89% up from last year.
  • Per Nutex Health's latest filing, its EBITDA stood at $130.7 million for FY2024, which was up 51133.89% from -$31.8 million recorded in FY2023.
  • Over the past 5 years, Nutex Health's EBITDA peaked at $170.3 million during FY2021, and registered a low of -$406.6 million during FY2022.
  • For the 5-year period, Nutex Health's EBITDA averaged around $3.2 million, with its median value being $130.7 million (2024).
  • Per our database at Business Quant, Nutex Health's EBITDA surged by 232588.81% in 2020 and then crashed by 33880.39% in 2022.
  • Over the past 5 years, Nutex Health's EBITDA (Annual) stood at $153.2 million in 2020, then increased by 11.15% to $170.3 million in 2021, then crashed by 338.8% to -$406.6 million in 2022, then surged by 92.19% to -$31.8 million in 2023, then surged by 511.34% to $130.7 million in 2024.
  • Its last three reported values are $130.7 million in FY2024, -$31.8 million for FY2023, and -$406.6 million during FY2022.